Showing 1,561 - 1,580 results of 1,835 for search '"Broad Institute"', query time: 0.28s Refine Results
  1. 1561
  2. 1562
  3. 1563
  4. 1564
  5. 1565
  6. 1566
  7. 1567
  8. 1568

    Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses by Iman Tavassoly, Yuan Hu, Shan Zhao, Chiara Mariottini, Aislyn Boran, Yibang Chen, Lisa Li, Rosa E. Tolentino, Gomathi Jayaraman, Joseph Goldfarb, James Gallo, Ravi Iyengar

    Published 2019-08-01
    “…We tested allopurinol, an FDA‐approved drug that inhibits XDH, on human non‐small‐cell lung cancer (NSCLC) cell lines obtained from the Broad Institute Cancer Cell Line Encyclopedia and identified sensitive and resistant cell lines. …”
    Get full text
    Article
  9. 1569

    Sanger Validation of High-Throughput Sequencing in Genetic Diagnosis: Still the Best Practice? by Rosina De Cario, Ada Kura, Samuele Suraci, Alberto Magi, Andrea Volta, Rossella Marcucci, Rossella Marcucci, Anna Maria Gori, Anna Maria Gori, Guglielmina Pepe, Guglielmina Pepe, Betti Giusti, Betti Giusti, Elena Sticchi, Elena Sticchi

    Published 2020-12-01
    “…Variants called following guidelines suggested by the Broad Institute and identified according to MAF <0.01 and allele balance >0.2 were Sanger validated. …”
    Get full text
    Article
  10. 1570

    Comparative transcriptional analysis of satellite glial cell injury response [version 1; peer review: 2 approved] by Lin Lin, Franziska Denk, Lone Tjener Pallesen, Alana Miranda Pinheiro, Francesca Izzi, Christian Bjerggaard Vaegter, Paolo Cesare, Sara Elgaard Jager, Sara Villa-Hernandez

    Published 2022-05-01
    “…Our results are available via the Broad Institute Single Cell Portal, so that readers can explore and search for genes of interest.…”
    Get full text
    Article
  11. 1571
  12. 1572
  13. 1573
  14. 1574
  15. 1575
  16. 1576
  17. 1577

    Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen by Sugandha Bhatia, Tony Blick, Cletus Pinto, Mark Waltham, James Monkman, Ekaterina Ivanova, Pamela M. Pollock, Shivashankar H. Nagaraj, Adrian P. Wiegmans, Izhak Haviv, Kaylene J. Simpson, Erik W. Thompson

    Published 2020-04-01
    “…We first identified candidate genes with depleted shRNA, implying that their silencing could promote a response. Using the Broad Institute’s Connectivity Map (CMap), we identified partner inhibitors targeting the identified gene families that may induce cell death in combination with doxorubicin, and tested them with all three drug treatments. …”
    Get full text
    Article
  18. 1578
  19. 1579
  20. 1580